Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib

[Figure: see text]

Detalles Bibliográficos
Autores principales: Piper-Vallillo, Andrew J., Sequist, Lecia V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352321/
https://www.ncbi.nlm.nih.gov/pubmed/34396180
http://dx.doi.org/10.1016/j.jaccao.2019.11.011
_version_ 1783736154856620032
author Piper-Vallillo, Andrew J.
Sequist, Lecia V.
author_facet Piper-Vallillo, Andrew J.
Sequist, Lecia V.
author_sort Piper-Vallillo, Andrew J.
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-8352321
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83523212021-08-13 Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib Piper-Vallillo, Andrew J. Sequist, Lecia V. JACC CardioOncol Original Research [Figure: see text] Elsevier 2019-12-17 /pmc/articles/PMC8352321/ /pubmed/34396180 http://dx.doi.org/10.1016/j.jaccao.2019.11.011 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Piper-Vallillo, Andrew J.
Sequist, Lecia V.
Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
title Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
title_full Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
title_fullStr Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
title_full_unstemmed Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
title_short Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
title_sort cardiac risk-informed treatment of egfr-mutant lung cancer with osimertinib
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352321/
https://www.ncbi.nlm.nih.gov/pubmed/34396180
http://dx.doi.org/10.1016/j.jaccao.2019.11.011
work_keys_str_mv AT pipervallilloandrewj cardiacriskinformedtreatmentofegfrmutantlungcancerwithosimertinib
AT sequistleciav cardiacriskinformedtreatmentofegfrmutantlungcancerwithosimertinib